Alice Blue Home
URL copied to clipboard

Trending News

Pharma stock: Shukra Pharmaceuticals shares hit upper circuit after receiving ₹24 Cr contract HSCC (India) Limited

Shukra Pharmaceuticals Limited has received a ₹24.06 crore contract from HSCC (India) Limited to supply medicines and diagnostic kits to Afghanistan’s Technical Mission of India.

Introduction

Leading pharmaceutical firm has received a ₹24.06 crore contract from HSCC (India) Limited to supply essential medicines and diagnostic kits to Afghanistan, including packing, insurance, and delivery at the Technical Mission of India, Kabul.

Alice Blue Image

Also Read: Semiconductor stock: CG Power stock jumps after launching new semiconductor facility with ₹7,600 Cr investment

Share price movement of Shukra Pharmaceuticals

On August 29, 2025, Shukra Pharmaceuticals Ltd opened at ₹26.22, up 1.98% from its previous close of ₹25.71. The stock recorded a high and low of ₹26.22. By 10:21 AM, it traded at ₹26.22 with a market cap of ₹1,148.12 crore.

Shukra Pharmaceuticals Bags ₹24 Crore Afghanistan Contract

Shukra Pharmaceuticals Limited has secured a contract from HSCC (India) Limited on behalf of the Ministry of External Affairs. The Letter of Award, dated August 28, 2025, is for supplying medicines and diagnostic kits to Afghanistan.

The contract is valued at ₹24.06 crore and includes packing, forwarding, insurance, and delivery at the consignee site in Kabul. Supplies will support the Technical Mission of India in Afghanistan.

Stock performance of Shukra Pharmaceuticals for Period of 1 week, 6 months, and 1 year

Shukra Pharmaceuticals Ltd delivered a 12.4% return over the past week, it gained 9.40% in the past six months. The stock surged 297% over the past year.

Alice Blue Image

Also Read: Pharma stock: Gland pharma receives USFDA approval for vasopressin in 5% dextrose RTU injection

Shareholding pattern of Shukra Pharmaceuticals

ParticularsJun 2025Mar 2025Dec 2024
Promoter51.00%51.00%51.00%
FII0.00%0.00%0.00%
DII0.10%0.10%0.10%
Public48.90%48.90%48.90%

About Shukra Pharmaceuticals

Shukra Pharmaceuticals Ltd (BSE: 524632), incorporated in 1993, is a WHO-GMP certified manufacturer of tablets, capsules, and small-volume parenterals, also engaged in laboratory testing and pharmaceutical product development and marketing.

Stay Ahead with the Latest Stock Market Updates – Click Here

Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.

FAQs

Q: Why is Shukra Pharmaceuticals Limited share price going up today?

A: Shukra Pharmaceuticals Limited share price is rising after securing a ₹24.06 crore contract from HSCC (India) Limited to supply medicines and diagnostic kits to Afghanistan.

Q: What does Shukra Pharmaceuticals Limited specialize in?

A: Shukra Pharmaceuticals Limited specializes in manufacturing and marketing pharmaceutical formulations like tablets, capsules, and small-volume parenterals, along with laboratory testing services.

Q: What is the market capitalization of Shukra Pharmaceuticals Limited?

A: The market capitalization of Shukra Pharmaceuticals Limited stands at ₹1,148.12 crore as of August 29, 2025.

Submit the form, and get to know how you scored!!!

Gainers & Losers

Read More News

*T&C apply